Kanada - angielski - Health Canada

gilead sciences canada inc - sofosbuvir - tablet - 400mg - sofosbuvir 400mg - miscellaneous antivirals

Kanada - angielski - Health Canada

gilead sciences canada inc - sofosbuvir; velpatasvir - tablet - 400mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg - hcv polymerase inhibitors

Kanada - angielski - Health Canada

gilead sciences canada inc - sofosbuvir; ledipasvir - tablet - 400mg; 90mg - sofosbuvir 400mg; ledipasvir 90mg - hcv polymerase inhibitors

Tanzania - angielski - Tanzania Medicinces & Medical Devices Authority

gilead sciences, inc, usa - ledipasvir 90mg/sofosbuvir 400mg - tablets - ledipasvir 90 mg/ sofosbuvir 400 mg

Australia - angielski - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - voxilaprevir, quantity: 100 mg; velpatasvir, quantity: 100 mg; sofosbuvir, quantity: 400 mg - tablet - excipient ingredients: lactose monohydrate; copovidone; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vosevi (sofosbuvir/velpatasvir/voxilaprevir fixed-dose combination) is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adult patients, without cirrhosis or with compensated cirrhosis, who have: - genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an hcv regimen containing an ns5a inhibitor; - genotype 1a or 3 infection and have previously been treated with an hcv regimen containing sofosbuvir without an ns5a inhibitor; (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties, clinical trials).

Izrael - angielski - Ministry of Health

eldan electronic instruments co ltd, israel - tetrofosmin - lyophilized powder for injection - tetrofosmin 0.23 mg/vial - indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.

Singapur - angielski - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - tetrofosmin (as tetrofosmin sulphosalicylate) - injection, powder, for solution - 0.23 mg/vial - tetrofosmin (as tetrofosmin sulphosalicylate) 0.23 mg/vial

Kanada - angielski - Health Canada

ge healthcare canada inc - tetrofosmin - powder for solution - 0.23mg - tetrofosmin 0.23mg - roentgenography

Kanada - angielski - Health Canada

ge healthcare canada inc - tetrofosmin - powder for solution - 1.38mg - tetrofosmin 1.38mg - roentgenography

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences international ltd - sofosbuvir - tablet - 400mg